Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC naming John Lahart .
Filed returns
14
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Janssen Sciences Ireland UC | Health | Meeting to discuss health products reimbursement process reform (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Health | Engagement with John Lahart TD on the Mazars process to reform the reimbursement system (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Government & Oireachtas members re new medicines funding. (Matters involving public funds) | 7 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Conversation with John Lahart TD (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Oireachtas members on the need for new development funding for new medicines reimbursements in 2024 (Matters involving public funds) | 24 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members on reform of the reimbursement process for newly approved medicines (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2023 | Janssen Sciences Ireland UC | Health | Sharing Information and Views on medicines reimbursement reform and IPHA campaign (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2023 | Janssen Sciences Ireland UC | Health | Sharing Information and views on medicines reimbursement reform and patient access (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: What will it mean for rare disease'' (Public policy or programme) | 15 | On lobbying.ie |
| Sep–Dec 2022 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: Opportunities to Improve Irish Healthcare' (Public policy or programme) | 23 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Health | Invite to webinar series on the 'Future of Value Based Healthcare in Ireland', RCSI Dublin (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Sharing information on European Beating Cancer Plan and impact on Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2021 | Janssen Sciences Ireland UC | Health | Sharing progress and information on Janssen COVID19 Vaccine clinical development, supply updates and public communication (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2020 | Janssen Sciences Ireland UC | Health | Sharing information on access to new medicines for Irish patients and COVID-19 vaccine update (Public policy or programme) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 12 | 85.7% | |
| Budgetary matters | 2 | 14.3% |